Literature DB >> 29967816

Differential Diagnosis and Management Issues of Idiopathic Angiooedema and their Resolution.

Andrea Zanichelli1, Marta Mansi1, Maddalena A Wu1, Giulia Azin1, Marco Cicardi1.   

Abstract

Angiooedema is a local and self-limiting swelling of the subcutaneous and sub mucosal tissues, produced by vasoactive peptides that temporary increase the vascular permeability. It is recognized that recurrent angiooedema exposes patients to the risk of fatalities and reduced quality of life, being in some circumstances associated with a critical condition. Angiooedema can occur with or without wheals. The first symptom is urticaria, the second is a distinct nosologic entity. In absence of an identifiable cause, recurrent angiooedema without wheals can be defined as idiopathic and marked"idiopathic histaminergic angiooedema" when it is responsive to anti histamine treatment, and "idiopathic non-histaminergic angiooedema" when it is not. Furthermore, idiopathic non-histaminergic angiooedema can be diagnosed as hereditary or sporadic by family history. In this review, we summarize the approaches to diagnose and treat different forms of idiopathic angiooedema.

Entities:  

Keywords:  C1 inhibitor; angiooedema; bradykinin; factor XII; idiopathic; tranexamic acid

Year:  2015        PMID: 29967816      PMCID: PMC5953287          DOI: 10.1515/jccm-2015-0008

Source DB:  PubMed          Journal:  J Crit Care Med (Targu Mures)        ISSN: 2393-1817


  40 in total

1.  Bradykinin-mediated angioedema.

Authors:  Juerg Nussberger; Massimo Cugno; Marco Cicardi
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

2.  Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema.

Authors:  A Du-Thanh; N Raison-Peyron; C Drouet; B Guillot
Journal:  Allergy       Date:  2009-11-03       Impact factor: 13.146

Review 3.  Hereditary angioedema with normal C1 inhibitor.

Authors:  Konrad Bork
Journal:  Immunol Allergy Clin North Am       Date:  2013-09-05       Impact factor: 3.479

4.  Successful treatment of idiopathic angioedema with ecallantide.

Authors:  Alalia Berry; Rafael Firszt
Journal:  J Allergy Clin Immunol Pract       Date:  2013-04-29

5.  Ecallantide for the treatment of acute attacks in hereditary angioedema.

Authors:  Marco Cicardi; Robyn J Levy; Donald L McNeil; H Henry Li; Albert L Sheffer; Marilyn Campion; Patrick T Horn; William E Pullman
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

6.  Economic costs associated with acute attacks and long-term management of hereditary angioedema.

Authors:  David A Wilson; Konrad Bork; Elizabeth P Shea; Anne M Rentz; Marc B Blaustein; William E Pullman
Journal:  Ann Allergy Asthma Immunol       Date:  2010-04       Impact factor: 6.347

7.  Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.

Authors:  Timothy J Craig; Robyn J Levy; Richard L Wasserman; Againdra K Bewtra; David Hurewitz; Krystyna Obtułowicz; Avner Reshef; Bruce Ritchie; Dumitru Moldovan; Todor Shirov; Vesna Grivcheva-Panovska; Peter C Kiessling; Heinz-Otto Keinecke; Jonathan A Bernstein
Journal:  J Allergy Clin Immunol       Date:  2009-09-19       Impact factor: 10.793

8.  Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients.

Authors:  C Wintenberger; I Boccon-Gibod; D Launay; O Fain; G Kanny; P Y Jeandel; L Martin; A Gompel; L Bouillet
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

9.  Benefits of progestin contraception in non-allergic angioedema.

Authors:  C Saule; I Boccon-Gibod; O Fain; G Kanny; G Plu-Bureau; L Martin; D Launay; L Bouillet; A Gompel
Journal:  Clin Exp Allergy       Date:  2013-04       Impact factor: 5.018

10.  Angioedema.

Authors:  Allen P Kaplan
Journal:  World Allergy Organ J       Date:  2008-06       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.